Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Total Revenue

Total Revenue at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.07B+19.1%
Alkermes logo
AlkermesALKS
$392.91M+28.2%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$191.2M+57.4%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.23M-96.1%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$722.52M+3.9%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$268.06M+9.7%

Segments

By segment

See full
Rare Neurological Diseases$215.39M+16.6%

Other financials

Income statement

See full
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s total revenue?
Harmony Biosciences Holdings, Inc. (HRMY) reported total revenue of $215.39M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s total revenue changed year-over-year?
Harmony Biosciences Holdings, Inc.'s total revenue increased by 16.6% year-over-year, from $184.73M to $215.39M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s total revenue?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s total revenue has grown at a 29.9% compound annual growth rate (CAGR), from $305.44M to $868.45M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.